Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.

Ozempic vs Wegovy

Editorial comparison of Ozempic (semaglutide) and Wegovy (semaglutide). Same drug class context, trial-anchored data, no marketing claims.

Reviewed by the WeighedHealth Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of July 2026; updated when guidance or availability changes.

Side-by-side

DimensionOzempicWegovy
Generic namesemaglutidesemaglutide
ManufacturerNovo NordiskNovo Nordisk
FDA approved20172021
MechanismSame mechanism as Wegovy — GLP-1 receptor agonist.Semaglutide mimics GLP-1, a gut hormone released after meals.
Dosing0.25mg weekly for 4 weeks, then 0.5mg, then 1mg, max 2mg. Lower max dose than Wegovy (2.4mg).Titrated over 4-5 months: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, increasing every 4 weeks.
CostList price ~$900-1,000/month.List price ~$1,350/month without insurance.
Pivotal trial result1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose)14.9% mean body-weight reduction at 68 weeks

Efficacy in the trials

Ozempic

1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose)

SUSTAIN-6 (NCT01720446) — cardiovascular outcomes · vs placebo, 26% reduction in major adverse cardiovascular events · n=3,297

Wegovy

14.9% mean body-weight reduction at 68 weeks

STEP 1 (NCT03548935) · vs 2.4% with placebo + lifestyle · n=1,961

Trial averages describe study populations, not individuals. Response varies with the dose tolerated, adherence, and personal physiology; the two drugs were not necessarily tested head-to-head in the same trial.

The details

Dosing & cadence

Ozempic: 0.25mg weekly for 4 weeks, then 0.5mg, then 1mg, max 2mg. Lower max dose than Wegovy (2.4mg).
Wegovy: Titrated over 4-5 months: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg, increasing every 4 weeks. Maintenance dose 2.4mg weekly. Slower titration is common to manage GI side effects.

Cost & access

Ozempic: List price ~$900-1,000/month. Diabetes coverage is generally better than weight-loss coverage — many insurance plans cover Ozempic with a T2D diagnosis at standard copay.
Wegovy: List price ~$1,350/month without insurance. With Novo Nordisk's patient assistance program, eligible self-pay patients can access at $200-500/month. Insurance coverage is patchy and often requires prior authorization plus a documented weight-related comorbidity.

Side effects

Ozempic: Same as Wegovy. Same MTC/MEN2 contraindication.
Wegovy: Most common: nausea (especially first 4-8 weeks), constipation, diarrhea, fatigue, headache. Less common: gallbladder issues, pancreatitis (rare), kidney strain if dehydrated. Black-box warning: medullary thyroid cancer risk (theoretical, based on rodent studies). Discontinue and consult clinician for severe abdominal pain or persistent vomiting.

Which should you choose?

If maximizing average trial weight loss is the priority, Wegovy posted the higher pivotal-trial figure; Ozempic still produced clinically meaningful loss and some people tolerate it better. On cost and access, compare each drug's manufacturer direct-pay and insurance path — that often matters more month-to-month than the efficacy gap. Both carry class safety considerations (see each drug's boxed-warning and contraindications); a personal or family history of medullary thyroid carcinoma or MEN2 rules out the GLP-1 class. Bring this comparison to a prescriber, who will match the drug to your history and titrate the dose.

This is editorial framing, not a prescription. The right choice depends on your medical history, insurance, and a clinician's evaluation.

Full Ozempic review →

FDA-approved semaglutide for type 2 diabetes. Widely used off-label for weight loss.

Full Wegovy review →

Once-weekly injectable semaglutide for chronic weight management. ~15% body weight loss in trials.

Deciding at the molecule level? Semaglutide vs Tirzepatide compares the two drug families behind every major GLP-1 brand.

Frequently asked

Is Ozempic or Wegovy more effective?+

In their pivotal trials, Ozempic reported 1.4–1.8% HbA1c reduction across SUSTAIN trials (1.0 mg dose), while Wegovy reported 14.9% mean body-weight reduction at 68 weeks. Head-to-head results vary by patient profile, dose tolerated, and adherence — these trial numbers describe averages, not what every individual experiences.

How do Ozempic and Wegovy compare on cost?+

Ozempic: List price ~$900-1,000/month. Diabetes coverage is generally better than weight-loss coverage — many insurance plans cover Ozempic with a T2D diagnosis at standard copay. Wegovy: List price ~$1,350/month without insurance. With Novo Nordisk's patient assistance program, eligible self-pay patients can access at $200-500/month. Insurance coverage is patchy and often requires prior authorization plus a documented weight-related comorbidity. Real out-of-pocket depends on insurance formulary tier, manufacturer savings programs, and whether a direct-pay channel is available.

Can I switch from Ozempic to Wegovy?+

Switching between brand-name treatments in the same drug class is common, but the conversion is not always 1:1. Discuss the switch with your prescriber — they'll usually re-titrate dosing rather than substitute equivalent strengths directly.

Are Ozempic and Wegovy the same drug?+

No. Ozempic (semaglutide) and Wegovy (semaglutide) are distinct medications from Novo Nordisk and Novo Nordisk respectively. They may share a drug class or mechanism but differ in active ingredient, dosing, and approved use.